Puma Biotechnology Inc. (NASDAQ:PBYI)

CAPS Rating: 1 out of 5

Caps

How do you think PBYI will perform against the market?

Add Stock to CAPS Watchlist

All Players

34 Outperform
24 Underperform
 

All-Star Players

10 Outperform
12 Underperform
 

Wall Street

2 Outperform
1 Underperform
 

Top PBYI Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

lookbeforeuleap (91.49)
Submitted November 15, 2014

a 10 bagger from 3/13/2013

TSIF (99.97)
Submitted July 23, 2014

I probably forced Puma Biotechnology a little bit on a downthumb. Risk/Reward probably gives me low odds of turning this one. Also, any down thumbs on a biopharm brings out the halos wondering how anyone could down thumb medical science especially in… More

PBYI VS S&P 500 (SPY)

Fools bullish on PBYI are also bullish on:

Fools bearish on PBYI are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about PBYI.

Recs

0
Member Avatar YourDailyBear (49.20) Submitted: 1/14/2016 1:28:07 PM : Underperform Start Price: $49.32 PBYI Score: -118.85

Puma has 0 Revenue and a $1.57 Billion market cap. Crazy overvalued and bearish trend.

Recs

0
Member Avatar CramersSkeeDaddy (< 20) Submitted: 7/23/2014 2:04:00 PM : Underperform Start Price: $232.11 PBYI Score: +75.00

up 300% in one day, enough said. Hopefully they do cure/treat all cancer but the short squeeze will likely end soon. No or little revenue, or earnings.

Recs

0
Member Avatar dabhsar (< 20) Submitted: 6/2/2013 8:56:29 AM : Outperform Start Price: $39.55 PBYI Score: +158.08

This small Bio Tech company is onto key medicine break through.

Leaderboard

Find the members with the highest scoring picks in PBYI.

Score Leader

portefeuille

portefeuille (98.74) Score: +333.12

The Score Leader is the player with the highest score across all their picks in PBYI.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
jeepdrew222 87.91 5/17/2016 Outperform 5Y $28.79 +331.23% +23.65% +307.58 0 Comment
oddlogic 64.34 5/8/2017 Outperform 5Y $30.45 +307.72% +6.48% +301.24 0 Comment
stereotyp72 64.74 1/24/2017 Outperform 5Y $31.25 +297.28% +12.76% +284.52 0 Comment
portefeuille 98.74 2/10/2016 Outperform 5Y $37.45 +231.51% +35.98% +195.53 0 Comment
portefeuille2 99.47 2/10/2016 Outperform 5Y $37.95 +227.14% +36.45% +190.69 0 Comment
jsamudio < 20 11/8/2013 Outperform 5Y $39.37 +215.34% +45.99% +169.35 0 Comment
dabhsar < 20 6/3/2013 Outperform 3Y $39.55 +213.91% +55.83% +158.08 1 Comment
LifeScientist 22.11 10/9/2013 Outperform 3M $40.38 +207.45% +54.66% +152.79 0 Comment
rajalonghorn 22.26 10/11/2013 Outperform 5Y $42.03 +195.38% +51.14% +144.24 0 Comment
Bobes915 79.33 8/2/2016 Outperform 5Y $49.11 +152.80% +17.84% +134.96 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackJimCramer 84.97 7/10/2015 Underperform 3W $106.25 +16.85% +23.04% +6.20 0 Comment
TrackCitigroup 93.26 4/21/2014 Outperform NS $74.73 +66.13% +36.93% +29.20 0 Comment
TrackUBS 93.56 12/19/2013 Outperform NS $98.76 +25.72% +40.90% -15.18 0 Comment

Featured Broker Partners